Experts unveil “breakthrough” map of key coronavirus protein

It could help chart the path to a COVID-19 vaccine.

Researchers have created an atomic-scale 3D map of the protein the novel coronavirus 2019-nCoV uses to infiltrate human cells — potentially a key milestone along the path to a vaccine.

Thanks to existing research on viruses, scientists from the University of Texas at Austin and the National Institutes of Health already knew that viruses use a “spike protein” to access and infect their host’s cells.

They also knew that understanding a virus’s spike protein can be useful in preventing its spread.

“The spike is really the antigen that we want to introduce into humans to prime their immune response to make antibodies against this, so that when they then see the actual virus, their immune systems are ready and loaded to attack,” lead researcher Jason McLellan at the UT Austin told Agence France-Presse.

“Structure of 2019-nCoV spike protein in the prefusion conformation This is a 3D atomic scale map, or molecular structure, of the 2019-nCoV spike protein. The protein takes on two different shapes, called conformations — one before it infects a host cell, and another during infection. This structure represents the protein before it infects a cell, called the prefusion conformation.” Image courtesy of Jason McLellan/Univ. of Texas at Austin.

McLellan’s team had firsthand experience studying coronaviruses similar to 2019-nCoV prior to the outbreak. They had even already developed methods for mapping the molecular structures of spike proteins, so once they obtained 2019-nCoV’s genome sequence from Chinese researchers, they set to work on mapping its spike protein.

The first step was identifying the genes that code for the spike protein and obtaining copies of those genes. Then, the UT Austin team injected the genes into cells in their lab, which prompted the cells to begin producing the spike protein.

Understanding a virus’s spike protein can be useful in preventing its spread.

After stabilizing the spike protein, the researchers mapped its atomic structure using a Nobel Prize-winning technique called “cryogenic electron microscopy,” which involved freezing the protein and then firing beams of electrons at it.

Less than a month after obtaining 2019-nCoV’s genome sequence, the UT Austin team submitted a manuscript on the virus’s spike protein to the journal Science, which fast-tracked the peer-review process in order to publish the research as quickly as possible.

“Jason S. McLellan, associate professor of molecular biosciences, left, and graduate student Daniel Wrapp, right, work in the McLellan Lab at The University of Texas at Austin Monday Feb. 17, 2020.” Image courtesy of Jason McLellan/Univ. of Texas at Austin.

“This is a beautifully clear structure of one of the most important coronavirus proteins — a real breakthrough in terms of understanding how this coronavirus finds and enters cells,” virologist Benjamin Neuman at the Texas A&M University-Texarkana, who was not involved in the work, told Agence France-Presse.

Still, identifying and mapping 2019-nCoV’s spike protein is just one step along the path to containing the ongoing coronavirus outbreak, which has already infected more than 75,000 people and killed at least 2,000.

Researchers at the NIH plan to inject the virus’s spike proteins into animals to see what sort of antibody production response they prompt. The UT Austin team is also sharing its molecular map of the spike protein with dozens of coronavirus research teams, in the hopes it will help in the development of a COVID-19 vaccine.

Ultimately, overcoming a global health emergency like the novel coronavirus will require a prolonged global response — and this team of scientists far from the outbreak’s epicenter just made a huge contribution to it.

Related
Something found in bats could help us survive infections and inflammation
This protein may help bats survive viral infections and could be the springboard for new anti-inflammatory drugs.
World’s first vaccine for RSV approved in the US
The FDA has approved the world’s first vaccine for RSV, a potentially deadly viral infection that has long eluded vaccination.
Ancient viruses in the human genome can help fight cancer
Armed with a DoD grant, researchers are harnessing the genetic code of ancient viral infections to fight prostate cancer.
A mosquito factory will create billions of biters in Brazil
The World Mosquito Project’s plan is to introduce bacteria-carrying mosquitoes to stop the spread of dengue.
Nasal COVID-19 vaccine outperforms mRNA shots in new study
A live attenuated vaccine for COVID-19 that delivered via a nasal spray outperformed several shots in a preclinical study.
Up Next
coronavirus vaccine
Subscribe to Freethink for more great stories